An independent AI tool for oncology evidence-based recommendations
Image credit: accuray via Unsplash
A study published in the journal Nature Cancer reports the development and validation of an autonomous artificial intelligence (AI) agent to support clinical decision-making in oncology. Leveraging multimodal patient data, spanning demographics, imaging, pathology, and treatment outcomes, the system generates real-time, evidence-based recommendations for diagnosis, therapy selection, and prognosis. When tested against GPT-4 alone, the integrated AI enhanced clinical accuracy from 30.3% to 87.2%, highlighting its potential to transform oncologic care by enhancing precision and supporting improved patient outcomes.
Source
Ferber, D., El Nahhas, O.S.M., Wölflein, G. et al. Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology. Nat Cancer (2025). https://doi.org/10.1038/s43018-025-00991-6
Additional Reading
https://www.nature.com/articles/s43018-025-00991-6
https://medicalxpress.com/news/2025-06-autonomous-ai-agent-clinical-decisions.html